Open access · CC-BY
via OpenAlex
Bone Marrow-Derived Mesenchymal Stem Cells-Derived Exosomes Promote Survival of Retinal Ganglion Cells Through miRNA-Dependent Mechanisms
Ben Mead, Stanislav I. Tomarev
Stem Cells Translational Medicine · 2017 · ▲ 488 citations
Abstract
The loss of retinal ganglion cells (RGC) and their axons is one of the leading causes of blindness and includes traumatic (optic neuropathy) and degenerative (glaucoma) eye diseases. Although no clinical therapies are in use, mesenchymal stem cells (MSC) have demonstrated significant neuroprotective and axogenic effects on RGC in both of the aforementioned models. Recent evidence has shown that MSC secrete exosomes, membrane enclosed vesicles (30-100 nm) containing proteins, mRNA and miRNA which can be delivered to nearby cells. The present study aimed to isolate exosomes from bone marrow-derived MSC (BMSC) and test them in a rat optic nerve crush (ONC) model. Treatment of primary retinal cultures with BMSC-exosomes demonstrated significant neuroprotective and neuritogenic effects. Twenty-one days after ONC and weekly intravitreal exosome injections; optical coherence tomography, electroretinography, and immunohistochemistry was performed. BMSC-derived exosomes promoted statistically significant survival of RGC and regeneration of their axons while partially preventing RGC axonal loss and RGC dysfunction. Exosomes successfully delivered their cargo into inner retinal layers and the effects were reliant on miRNA, demonstrated by the diminished therapeutic effects of exosomes derived from BMSC after knockdown of Argonaute-2, a key miRNA effector molecule. This study supports the use of BMSC-derived exosomes as a cell-free therapy for traumatic and degenerative ocular disease. Stem Cells Translational Medicine 2017;6:1273-1285.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1002/sctm.16-0428
- Canonical
- link ↗
- Fetched
- 2026-09-04 MST
Cite this
APA
Mead, B., & Tomarev, S.I. (2017). Bone Marrow-Derived Mesenchymal Stem Cells-Derived Exosomes Promote Survival of Retinal Ganglion Cells Through miRNA-Dependent Mechanisms. <em>Stem Cells Translational Medicine</em>. https://doi.org/10.1002/sctm.16-0428
Vancouver
Mead B, Tomarev SI. Bone Marrow-Derived Mesenchymal Stem Cells-Derived Exosomes Promote Survival of Retinal Ganglion Cells Through miRNA-Dependent Mechanisms. Stem Cells Translational Medicine. 2017. doi:10.1002/sctm.16-0428.
BibTeX
@article{ben2017BoneMa,
title = {Bone Marrow-Derived Mesenchymal Stem Cells-Derived Exosomes Promote Survival of Retinal Ganglion Cells Through miRNA-Dependent Mechanisms},
author = {Ben Mead and Stanislav I. Tomarev},
journal = {Stem Cells Translational Medicine},
year = {2017},
doi = {10.1002/sctm.16-0428},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Clinical Interventions in Aging 2013
Open access · CC-BY
Bone marrow mesenchymal stem cells protect against retinal ganglion cell loss in aged rats with glaucoma
Cells 2021
Open access · CC-BY
Mesenchymal Stem Cell-Based Therapy for Retinal Degenerative Diseases: Experimental Models and Clinical Trials
International Journal of Molecular Sciences 2018
Open access · CC-BY
Mesenchymal Stem Cell Migration during Bone Formation and Bone Diseases Therapy
International Journal of Molecular Sciences 2025
Open access · CC-BY
Dasatinib and Quercetin Alleviate Retinal Ganglion Cell Dendritic Shrinkage and Promote Axonal Regeneration in Mice with Optic Nerve Injury
International Journal of Oral Science 2009
Open access · OA
Mesenchymal Stem Cells and Tooth Engineering
Simpósio Internacional de Neurociências da Grande Dourados 2015
Citation only